Company: CGC
Filing Date: 2025-02-07
Form Type: 10-Q
Source: 0000950170-25-015839
Chunk: 294

Company: Canopy Growth Corp
Filing Date: 2025-02-07
Form: 10-Q
Item: Item 8
Chunk 294
---
atively, in the nine months ended December 31, 2023, our strategic investments in other financial assets were $0.5 million and related primarily to our investment in Indiva.

 Net redemptions of short-term investments in the nine months ended December 31, 2024 were $17.0 million, as compared to net redemptions of $68.3 million in the nine months ended December 31, 2023. The year-over-year decrease in the net redemptions reflects the continued redemption of our short-term investments, largely to fund operations and investing activities as described above. As at December 31, 2024, we had short-term investments remaining of $16.4 million.

Net cash flow on sale or deconsolidation of subsidiaries in the nine months ended December 31, 2024 was an outflow of $7.0 million and related to the deconsolidation of Canopy USA, refer to Note 3 in the Company’s accompanying financial statements for details. Comparatively, net cash flow in the nine months ended December 31, 2023 was an outflow of $3.7 and related to the completion of the This Works Divestiture.

Additional cash inflows during the nine months ended December 31, 2024 include proceeds of $4.9 million from the sale of property, plant and equipment, primarily in relation to previous restructuring actions. Comparatively, additional cash inflows during the nine months ended December 31, 2023 include proceeds of $153.8 million from the sale of property, plant and equipment, primarily relating to facilities sold in connection with the restructuring actions associated with our Canadian cannabis operations and transition to an asset-light model.

Finally, net cash flow on loan receivable and other investing activities resulted in a cash inflow of $28.4 million in the nine months ended December 31, 2024, primarily related to cash receipts from various loan repayments. Comparatively, net cash flow on loan receivable and other investing activities in the nine months ended December 31, 2023 of $9.2 million primarily related to completing the purchase of the remaining 45% of the common shares of Les Serres Vert Cannabis Inc., in connection with the restructuring actions related to our Canadian cannabis operations initiated in the fourth quarter of fiscal 2023.

56

Financing activities

The cash provided by financing activities in the nine months ended December 31, 2024 was $164.6 million, as